CBIO
Conviction 42HealthcareScan · Thu, Sep 24, 2026Crescent Biopharma, Inc. (CBIO) closed at $14.24 (+0.35%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 32, RS Rating 48, -47.2% from its 52-week high, +28.5% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in CBIO
Insider activity
SEC Form 4 transactions in CBIO
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Violin Jonathan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Moran Susan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Healthcare Fund II L.P. Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Fairmount Funds Management LLC Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Lubner David Charles Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Harwin Peter Evan Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Kiselak Tomas Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
Balcom Alexandra Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 11.05K | $0 | 2026-06-02 | 2026-06-03 |
SEC filings
EDGAR filings in CBIO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.